MAPK3 and central nervous system cancer: Overall, as shown in Figure 13, TMZ required [Ca2+]i-dependent glycogenolysis, which led to Na,K-ATPase/ERK1/2 phosphorylation and the upregulation of these proteins, as well as MGMT activation which induced TMZ-resistance in glioma cells.